Minaris Advanced Therapies
Minaris Advanced Therapies, formed from Minaris Regenerative Medicine and the U.S. and U.K. operations of the Advanced Therapies unit spun out of WuXi AppTec, has a proven track record, delivering 7,500+ GMP lots to date, and continues to produce and release commercial therapies globally. We accelerate cell therapy programs from early development through commercialization and long-term supply.